Kasinger James R.'s Form 4 filing
CRISPR Therapeutics AG (CRSP) · filed Mar 12, 2024
- Accession no.
- 0000950170-24-030190
- Filed
- Mar 12, 2024
- Trade date
- Mar 10-12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $304.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kasinger James R.CIK 0001708172 | Officer (General Counsel and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2024 | Common Shares | MOption exerciseAcquired | +5,500 | – | – | 62,871 | Direct | |
| Mar 11, 2024 | Common Shares | SSaleDisposed | −2,801 | $78.26 | −$219,206.26 | 60,070 | Direct | |
| Mar 11, 2024 | Common Shares | MOption exerciseAcquired | +2,250 | – | – | 62,320 | Direct | |
| Mar 12, 2024 | Common Shares | SSaleDisposed | −1,146 | $74.44 | −$85,308.24 | 61,174 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2024 | Common Shares | MOption exerciseDisposed | −5,500 | – | – | 16,500 | Direct | |
| Mar 11, 2024 | Common Shares | MOption exerciseDisposed | −2,250 | – | – | 2,250 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.